Home › Funds › BlackRock Inc › RLAY
BlackRock Inc position in RLAY
RELAY THERAPEUTICS INC · Health Care
Latest position (Q2 2026)15.29M sh
Reported value held$286.04M
Portfolio Weight0.00%
First reportedQ3 2024
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 11.74M | $83.13M | New |
| Q4 2024 | 14.67M | $60.46M | Add |
| Q1 2025 | 14.48M | $37.93M | Reduce |
| Q2 2025 | 13.95M | $48.28M | Reduce |
| Q3 2025 | 13.76M | $71.82M | Reduce |
| Q4 2025 | 13.23M | $111.91M | Reduce |
| Q1 2026 | 12.98M | $129.10M | Reduce |
| Q2 2026 | 15.29M | $286.04M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding RLAY
- Fidelity Management & Research (FMR) 20.11M sh · $376.26M · Q2 2026
- Casdin Capital 16.04M sh · $300.02M · Q2 2026
- Geode Capital Management 4.73M sh · $88.45M · Q2 2026
- Vanguard Group 9.69M sh · $81.99M · Q4 2025
- Morgan Stanley 3.85M sh · $72.05M · Q2 2026
- Goldman Sachs Group 3.41M sh · $63.78M · Q2 2026
- Bank of America Corp 2.70M sh · $50.43M · Q2 2026
- Arrowstreet Capital 2.24M sh · $41.89M · Q2 2026
- Northern Trust Corp 1.95M sh · $36.55M · Q2 2026
- Franklin Resources 1.86M sh · $34.74M · Q2 2026
- Charles Schwab Investment Management 1.50M sh · $28.08M · Q2 2026